<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101487384</journal-id><journal-id journal-id-type="pubmed-jr-id">37890</journal-id><journal-id journal-id-type="nlm-ta">J Infect Public Health</journal-id><journal-id journal-id-type="iso-abbrev">J Infect Public Health</journal-id><journal-title-group><journal-title>Journal of infection and public health</journal-title></journal-title-group><issn pub-type="ppub">1876-0341</issn><issn pub-type="epub">1876-035X</issn></journal-meta><article-meta><article-id pub-id-type="pmid">40886605</article-id><article-id pub-id-type="pmc">12771690</article-id><article-id pub-id-type="doi">10.1016/j.jiph.2025.102937</article-id><article-id pub-id-type="manuscript">HHSPA2108614</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Melioidosis presenting as septic arthritis in hip joint of a 60-year old patient: Findings from a hospital-based surveillance in Bangladesh</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ananna</surname><given-names>Ayesha Jamal</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Barai</surname><given-names>Lovely</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Ahmed</surname><given-names>Jamal Uddin</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Islam</surname><given-names>Jubaidul</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Rahim</surname><given-names>Muhammad Abdur</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Das</surname><given-names>Tushar Kumar</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Chisty</surname><given-names>Nurun Nahar</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Akter</surname><given-names>Saima</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Gee</surname><given-names>Jay E.</given-names></name><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Gulvik</surname><given-names>Christopher A.</given-names></name><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Schrodt</surname><given-names>Caroline A.</given-names></name><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Weiner</surname><given-names>Zachary P.</given-names></name><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Chowdhury</surname><given-names>Sukanta</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>a</label>International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh</aff><aff id="A2"><label>b</label>Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM) General Hospital, Dhaka, Bangladesh</aff><aff id="A3"><label>c</label>Bacterial Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, United States</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Authors contributions</p><p id="P2">A.J.A and S.C. participated in conceptualization and methodology. A.J.A., L.B, J.U.A, J.I, A.R, T.K.D, N.N.C, S.A, C.A.S and S.C worked on analysis, and A.J.A prepared the manuscripts. J.E.G, C.A.G and Z.P.W performed genome sequencing and interpreted results. C.A.S and S.C. contributed to the supervision of methodology, data analysis, and manuscript edition. A.J.A., L.B, J.U.A, J.I, A.R, T.K.D, N.N.C, S.A, C.A.S and S.C participated in manuscript edition.</p></fn><corresp id="CR1"><label>*</label> Corresponding author. <email>sukanta@icddrb.org</email> (S. Chowdhury).</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>4</day><month>12</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>29</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>06</day><month>1</month><year>2026</year></pub-date><volume>18</volume><issue>10</issue><fpage>102937</fpage><lpage>102937</lpage><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p></license></permissions><abstract id="ABS1"><p id="P3">Melioidosis is a fatal bacterial infection caused by a soil-borne bacterium <italic toggle="yes">Burkholderia pseudomallei</italic>. Pneumonia, localized abscess and acute septicemia are the most common clinical presentations for melioidosis. Septic arthritis is relatively uncommon clinical manifestation and may cause severe infection. Here, we report a melioidosis case of a 60-year old diabetic male presenting with fever and acute hip pain. <italic toggle="yes">B. pseudomallei</italic> was isolated from blood culture and it was sensitive to meropenem, amoxicillin-clavulanic acid, cotrimoxazole, ceftazidime and doxycycline. The genome sequence from the clinical isolate obtained from this patient clusters with other Bangladeshi strains and it is within the major clade of East and Southeast Asia strains. The patient received parental meropenem for four weeks followed by six months of oral cotrimoxazole and doxycycline. We followed up the patients every three months over the past seven months. After seven months of oral antibiotic therapy, the patient fully recovered without feeling pain in hip joint and no further complications. His blood culture was tested negative after seven months. The findings of the case report are valuable for raising clinical suspicion and prompting laboratory testing to detect melioidosis. The report also detailed the disease progression and the response to antibiotic therapy.</p></abstract><kwd-group><kwd>Burkholderia pseudomallei</kwd><kwd>Septic arthritis</kwd><kwd>Bangladesh</kwd></kwd-group></article-meta></front><body><sec id="S1"><title>Introduction</title><p id="P4">Melioidosis is a deadly infection caused by the gram-negative bacterium <italic toggle="yes">Burkholderia pseudomallei</italic>, found in soil and water and transmitted via skin contact, ingestion, or inhalation [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref>]. Melioidosis is highly prevalent in tropical countries, especially in Southeast Asia and Northern Australia [<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref>]. Case fatality rate may reach up to 40 %, even with treatment [<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref>]. Conditions like diabetes, chronic lung, liver or kidney disease, cancer, heavy alcohol use, and other immune-suppressive states increase the risk and severity of melioidosis [<xref rid="R6" ref-type="bibr">6</xref>]. Agricultural farmers with frequent soil and water exposure are especially vulnerable, with most cases occurring during the monsoon season [<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref>]. The major clinical manifestations include pneumonia, localized abscess and acute septicaemia [<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref>]. Melioidosis cases involving septic arthritis and osteomyelitis are infrequent, with the knee being the most commonly affected joint, followed by the ankle, hip, and shoulder [<xref rid="R11" ref-type="bibr">11</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref>]. Bangladesh reported over 100 melioidosis cases, most presenting with pneumonia, skin abscesses, urinary tract infections, or acute septicaemia [<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref>]. In 2023, we detected a melioidosis case with left hip septic arthritis through hospital-based active surveillance. This case report outlines the clinical presentation, laboratory diagnosis, treatment approach, and patient outcome.</p><sec id="S2"><title>Case presentation</title><p id="P5">A 60-year-old man from Sherpur, Bangladesh, was admitted to BIRDEM hospital on July 20, 2023, with a 34-day history of fever, loss of appetite, and over three weeks of upper chest pain. On hospital admission, the patient had severely restricted movement in the left hip, which was mildly warm but showed no swelling. His vital signs (body temperature, pulse, respiratory rate, and blood pressure) were normal, and he was on oral antihypertensive medications. He had type 2 diabetes for over 20 years and hypertension for 8 years. He also had a history of pulmonary tuberculosis 20 years ago, which was cured after treatment. According to his clinical history, the patient was in good health until five weeks ago when he developed a continuous fever, with night time temperatures reaching 103&#x000b0;F-104&#x000b0;F, along with chills and rigors. He also experienced a burning sensation while urinating, which could be indicative of urinary tract infection (UTI). He consulted a physician, who, after a primary examination, recommended routine tests for the fever. The Complete Blood Count (CBC) showed normal (haemoglobin: 12.4 g/dl, leucocytosis: 12,300/cu mm with 75 % neutrophils) with elevated ESR (105 mm), and CRP (48 mg/l). The WIDAL test was negative, and random blood sugar was 16.2 mmol/L. He was initially treated with cefixime and ceftriaxone for seven days, but his condition did not improve. He was then admitted to Sherpur District Hospital and treated for UTI with intravenous Meropenem for eight days. He recovered from the urinary tract infection, but his fever persisted. He then developed upper chest pain and visited BIRDEM Hospital, a specialized diabetes care facility in Dhaka. After clinical evaluation, he was diagnosed with pyrexia of unknown origin, acute kidney injury, diabetes, and hypertension. He was initially treated with intravenous Ceftazidime 1 g twice daily for the first four days. Two days after admission, his fever subsided, but he developed severe pain in the left hip joint and inguinal region, along with swelling in the left inguinal area and upper chest pain. The hip pain progressively confined him to bed, with no pain in other joints.</p><p id="P6">Blood, sputum, and urine samples were collected on admission for routine tests and culture. The blood culture showed <italic toggle="yes">B. pseudomallei</italic> colonies on blood and MacConkey agar, with gram-negative bacilli and bipolar staining. On Ashdown media, the colonies were wrinkled and deep pink to purple. The bacteria were sensitive to meropenem, ceftazidime, amoxicillin-clavulanic acid, cotrimoxazole, and doxycycline, but resistant to gentamicin, amikacin, and colistin. Immunochromatography tests for malaria and kala-azar were negative.</p><p id="P7">The CBC showed elevated white blood cell count with increased polymorphonuclear leukocytes, along with high ESR, CRP, serum AST, ALT, blood sugar, and HbA1c levels (<xref rid="T1" ref-type="table">Table 1</xref>). Urine analysis showed 0&#x02013;2 WBCs/HPF, 0&#x02013;3 epithelial cells/HPF, 0&#x02013;2 RBCs/HPF, presence of glucose and albumin, and acetone negative. Urine culture showed no growth. X-rays of the chest and hip, Magnetic Resonance Imaging (MRI) of the left hip, and an inguinal ultrasound were performed. MRI findings indicated septic arthritis in the left hip joint, showing altered signal intensities in the femoral head, neck, and surrounding muscles, with joint space widening and mild fluid accumulation (<xref rid="F1" ref-type="fig">Fig. 1</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 1</xref>). Multiple mildly enlarged lymph nodes were noted in both inguinal regions, with no bone abnormalities (<xref rid="SD3" ref-type="supplementary-material">Supplementary Figure 2</xref>). The chest X-ray was normal (<xref rid="SD2" ref-type="supplementary-material">Supplementary Figure 3</xref>). The chest pain might be a result of lung involvement associated with pneumonia. Ultrasound showed a few enlarged lymph nodes in the left inguinal region, the largest measuring 15 &#x000d7; 7 mm, with no hernia, mass, or fluid collection.</p><p id="P8">The phylogenetic tree of <italic toggle="yes">B. pseudomallei</italic> (<xref rid="F2" ref-type="fig">Fig. 2</xref>) shows that the genome sequence from the clinical isolate (strain B0557 &#x02013; red branch) obtained from this patient clusters with other Bangladeshi strains and it is within the major clade of East and Southeast Asia strains (red dotted circle), but unfortunately no other detailed disease information exists for those isolates besides causing melioidosis. While such extensive case information is lacking for strain B0557&#x02019;s near neighbours, including a comprehensive tree will enable a future lookback if more isolates are gathered in the future with or without septic arthritis.</p><p id="P9">After confirming <italic toggle="yes">B. pseudomallei</italic> infection, the patient received intravenous meropenem (1 g every 12 h) for four weeks, followed by oral cotrimoxazole and doxycycline (100 mg every 12 h) for six months. He was referred to orthopaedics and physical medicine for hip joint pain and rehabilitation exercises. His pain gradually subsided, inflammatory markers normalized, and WBC count returned to normal by day 13 (Supplementary Table 1). Under close follow-up, he fully recovered after seven months, with no joint pain or complications. Follow-up blood cultures were negative.</p><p id="P10">The patient, a former businessman, had been homebound for the past five years. A day before symptom onset, he was exposed to soil and water while farming. He had also cared for a sick cow over four months, which died a month after his melioidosis diagnosis. He had no travel history in the past year and no history of smoking, alcohol, or drug use.</p></sec></sec><sec id="S3"><title>Discussion</title><p id="P11">Diagnosis of melioidosis in Bangladesh is challenging due to its diverse clinical presentations, limited diagnostic facilities with adequately trained personnel and insufficient attention from healthcare authorities. This case report provides valuable insight into a relatively uncommon clinical presentation and its successful treatment, which may aid clinicians in managing similar cases. The patient was referred from a rural area located a considerable distance from the study hospital. We systematically recorded the patient&#x02019;s clinical history, healthcare-seeking behaviour, and disease progression. This case reflects the limitations of diagnostic services outside Dhaka and illustrates the potential risks of misdiagnosis, inappropriate treatment, and prolonged suffering. The case presented a range of symptoms throughout the course of the illness, including chest pain, UTI, severe pain in the left hip joint and inguinal region, as well as fever. The distribution of <italic toggle="yes">B. pseudomallei</italic> in the environment spans a wide geographical range, including areas where cases are reported either frequently or sporadically. Clinical manifestations reported from various countries are diverse and often challenging to diagnose. Although relatively uncommon, septic arthritis has been documented in patients with melioidosis [<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R13" ref-type="bibr">13</xref>]. The differential diagnosis, including pathogens like <italic toggle="yes">B. pseudomallei</italic>, <italic toggle="yes">Staphylococcus aureus</italic>, and <italic toggle="yes">Haemophilus influenzae</italic>, makes diagnosing melioidosis particularly challenging [<xref rid="R3" ref-type="bibr">3</xref>]. A significant number of osteomyelitis and septic arthritis cases have been reported from melioidosis-endemic countries [<xref rid="R7" ref-type="bibr">7</xref>]. Large joints, such as the knee, ankle, elbow, hip, and shoulder, are commonly affected by <italic toggle="yes">B. pseudomallei</italic>, similar to other pathogens. Symptoms in lower extremity joints have also been reported [<xref rid="R12" ref-type="bibr">12</xref>].</p><p id="P12">This case of melioidosis was distinctive because it presented with involvement of the hip joint. Following bloodstream entry, <italic toggle="yes">Burkholderia pseudomallei</italic> disseminates to distant sites, including the lungs, liver, spleen, brain, and joints [<xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R17" ref-type="bibr">17</xref>]. In this patient, long-standing poorly controlled diabetes and frequent exposure to mud could facilitate widespread dissemination. A large number of patients from Northern Australia and Thailand showed similar clinical presentations [<xref rid="R3" ref-type="bibr">3</xref>]. In Australia, pneumonia was the most common presenting feature in 50 % of cases, while septic arthritis was observed in only 4 % of cases [<xref rid="R3" ref-type="bibr">3</xref>]. South China reported 19 patients with septic arthritis due to <italic toggle="yes">B. pseudomallei</italic> [<xref rid="R18" ref-type="bibr">18</xref>]. Diagnosing melioidosis remains challenging in Bangladesh, especially with rare clinical presentations and limited resources for culturing <italic toggle="yes">B. pseudomallei</italic>.</p></sec><sec id="S4"><title>Conclusion</title><p id="P13">This case report describes a distinct form of melioidosis with septic arthritis in the hip joint from a rural area, treated at a specialized hospital, emphasizing the importance of clinical suspicion, proper diagnosis, and timely appropriate treatment. It highlights the need for nationwide physician training on recognizing and managing both typical and atypical presentations of melioidosis.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>Supplemental Figure: MRI of Left Hip joint</label><media xlink:href="NIHMS2108614-supplement-Supplemental_Figure__MRI_of_Left_Hip_joint.docx" id="d67e361" position="anchor"/></supplementary-material><supplementary-material id="SD2" position="float" content-type="local-data"><label>Supplemental Figure: Xray of left hip joint</label><media xlink:href="NIHMS2108614-supplement-Supplemental_Figure__Xray_of_left_hip_joint.jpg" id="d67e364" position="anchor"/></supplementary-material><supplementary-material id="SD3" position="float" content-type="local-data"><label>Supplemental Figure: Xray of chest</label><media xlink:href="NIHMS2108614-supplement-Supplemental_Figure__Xray_of_chest.jpg" id="d67e367" position="anchor"/></supplementary-material></sec></body><back><ack id="S6"><title>Acknowledgement</title><p id="P14">We gratefully acknowledge icddr,b core donors (Government of Bangladesh and Canada) for their unrestricted support. We are thankful to the laboratory staffs of microbiology department, BIRDEM hospital. Specially we are grateful to Mar&#x000ed;a E Negron, Bacterial Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, United States of America.</p><sec id="S7"><title>Funding</title><p id="P15">The melioidosis surveillance was funded by the Centers for Disease Control and Prevention, USA (cooperative agreement no. U01GH002403).</p></sec></ack><fn-group><fn id="FN2"><p id="P17">Ethical approval statement</p><p id="P18">The melioidosis surveillance protocol was reviewed and approved by the Institutional Review Board of icddr,b (PR-20096). The patient provided informed, written consent to participate in the study.</p></fn><fn id="FN3"><p id="P19">Disclaimer</p><p id="P20">The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. This work was supported by CDC Emerging Infectious Disease funds.</p></fn><fn fn-type="COI-statement" id="FN4"><p id="P21">Declaration of Competing Interest</p><p id="P22">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></fn></fn-group><sec sec-type="data-availability" id="S5"><title>Data availability</title><p id="P16">The data that support the findings of this case report are available on request from the corresponding authors.</p></sec><app-group><app id="APP1"><title>Appendix A. Supporting information</title><p id="P23"><xref rid="SD1" ref-type="supplementary-material">Supplementary data</xref> associated with this article can be found in the online version at doi:<ext-link xlink:href="http://doi.org/10.1016/j.jiph.2025.102937" ext-link-type="uri">10.1016/j.jiph.2025.102937</ext-link>.</p></app></app-group><glossary><title>Abbreviations:</title><def-list><def-item><term>ALT</term><def><p id="P24">Alanine aminotransferase</p></def></def-item><def-item><term>AST</term><def><p id="P25">Aspartate aminotransferase</p></def></def-item><def-item><term>BIRDEM</term><def><p id="P26">Bangladesh institute of research and rehabilitation in diabetes, endocrine and metabolic disorders</p></def></def-item><def-item><term>CBC</term><def><p id="P27">Complete blood count</p></def></def-item><def-item><term>CRP</term><def><p id="P28">C-reactive Protein</p></def></def-item><def-item><term>ESR</term><def><p id="P29">Erythrocyte sedimentation rate</p></def></def-item><def-item><term>HPF</term><def><p id="P30">High-power field</p></def></def-item><def-item><term>HbA1c</term><def><p id="P31">Hemoglobin A1c</p></def></def-item><def-item><term>MRI</term><def><p id="P32">Magnetic resonance imaging</p></def></def-item><def-item><term>RBC</term><def><p id="P33">Red blood cell</p></def></def-item><def-item><term>UTI</term><def><p id="P34">Urinary tract infection</p></def></def-item><def-item><term>WBC</term><def><p id="P35">White blood cells</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><name><surname>Cheng</surname><given-names>AC</given-names></name>, <name><surname>Currie</surname><given-names>BJ</given-names></name>. <article-title>Melioidosis: epidemiology, pathophysiology, and management</article-title>. <source>Clin Microbiol Rev</source>
<year>2007</year>;<volume>20</volume>:<fpage>533</fpage>.</mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><name><surname>Amadasi</surname><given-names>S</given-names></name>, <name><surname>Dal Zoppo</surname><given-names>S</given-names></name>, <name><surname>Bonomini</surname><given-names>A</given-names></name>, <name><surname>Bussi</surname><given-names>A</given-names></name>, <name><surname>Pedroni</surname><given-names>P</given-names></name>, <name><surname>Balestrieri</surname><given-names>G</given-names></name>, <etal/>
<article-title>A case of melioidosis probably acquired by inhalation of dusts during a helicopter flight in a healthy traveler returning from Singapore</article-title>. <source>J Travel Med</source>
<year>2015</year>;<volume>22</volume>:<fpage>57</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">25183194</pub-id>
</mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><name><surname>Cheng</surname><given-names>AC</given-names></name>, <name><surname>Currie</surname><given-names>BJ</given-names></name>. <article-title>Melioidosis: epidemiology, pathophysiology, and management</article-title>. <source>Clin Microbiol Rev</source>
<year>2005</year>;<volume>18</volume>:<fpage>383</fpage>&#x02013;<lpage>416</lpage>.<pub-id pub-id-type="pmid">15831829</pub-id>
</mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><name><surname>Chowdhury</surname><given-names>S</given-names></name>, <name><surname>Barai</surname><given-names>L</given-names></name>, <name><surname>Afroze</surname><given-names>SR</given-names></name>, <name><surname>Ghosh</surname><given-names>PK</given-names></name>, <name><surname>Afroz</surname><given-names>F</given-names></name>, <name><surname>Rahman</surname><given-names>H</given-names></name>, <etal/>
<article-title>The epidemiology of melioidosis and its association with diabetes mellitus: a systematic review and meta-analysis</article-title>. <source>Pathogens</source>
<year>2022</year>;<volume>11</volume>:<fpage>149</fpage>.<pub-id pub-id-type="pmid">35215093</pub-id>
</mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><name><surname>Melioidosis</surname><given-names>White N.</given-names></name>
<source>Lancet</source>
<year>2003</year>;<volume>361</volume>:<fpage>1715</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">12767750</pub-id>
</mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><name><surname>Wiersinga</surname><given-names>WJ</given-names></name>, <name><surname>Virk</surname><given-names>HS</given-names></name>, <name><surname>Torres</surname><given-names>AG</given-names></name>, <name><surname>Currie</surname><given-names>BJ</given-names></name>, <name><surname>Peacock</surname><given-names>SJ</given-names></name>, <name><surname>Dance</surname><given-names>DA</given-names></name>, <etal/>
<source>Melioidosis. Nat Rev Dis Prim</source>
<year>2018</year>;<volume>4</volume>:<fpage>1</fpage>&#x02013;<lpage>22</lpage>.</mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><name><surname>Limmathurotsakul</surname><given-names>D</given-names></name>, <name><surname>Peacock</surname><given-names>SJ</given-names></name>. <article-title>Melioidosis: a clinical overview</article-title>. <source>Br Med Bull</source>
<year>2011</year>;<volume>99</volume>:<fpage>125</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">21558159</pub-id>
</mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><name><surname>Zheng</surname><given-names>X</given-names></name>, <name><surname>Xia</surname><given-names>Q</given-names></name>, <name><surname>Xia</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>W</given-names></name>. <article-title>Endemic melioidosis in Southern China: past and present</article-title>. <source>Trop Med Infect Dis</source>
<year>2019</year>;<volume>4</volume>:<fpage>39</fpage>.<pub-id pub-id-type="pmid">30823573</pub-id>
</mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><name><surname>Chaowagul</surname><given-names>W</given-names></name>, <name><surname>White</surname><given-names>NJ</given-names></name>, <name><surname>Dance</surname><given-names>DA</given-names></name>, <name><surname>Wattanagoon</surname><given-names>Y</given-names></name>, <name><surname>Naigowit</surname><given-names>P</given-names></name>, <name><surname>Davis</surname><given-names>TM</given-names></name>, <etal/>
<article-title>Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand</article-title>. <source>J Infect Dis</source>
<year>1989</year>;<volume>159</volume>:<fpage>890</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">2708842</pub-id>
</mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><name><surname>Currie</surname><given-names>BJ</given-names></name>, <name><surname>Mayo</surname><given-names>M</given-names></name>, <name><surname>Ward</surname><given-names>LM</given-names></name>, <name><surname>Kaestli</surname><given-names>M</given-names></name>, <name><surname>Meumann</surname><given-names>EM</given-names></name>, <name><surname>Webb</surname><given-names>JR</given-names></name>, <etal/>
<article-title>The Darwin prospective melioidosis study: a 30-year prospective, observational investigation</article-title>. <source>Lancet Infect Dis</source>
<year>2021</year>;<volume>21</volume>:<fpage>1737</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="pmid">34303419</pub-id>
</mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><name><surname>Arunpriyandan</surname><given-names>V</given-names></name>, <name><surname>Pakkiyaretnam</surname><given-names>M</given-names></name>, <name><surname>Umakanth</surname><given-names>M</given-names></name>. <article-title>Systemic melioidosis presenting as septic arthritis</article-title>. <source>Cureus</source>
<year>2022</year>;<fpage>14</fpage>.</mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><name><surname>Teparrukkul</surname><given-names>P</given-names></name>, <name><surname>Nilsakul</surname><given-names>J</given-names></name>, <name><surname>Dunachie</surname><given-names>S</given-names></name>, <name><surname>Limmathurotsakul</surname><given-names>D</given-names></name>. <article-title>Clinical epidemiology of septic arthritis caused by burkholderia pseudomallei and other bacterial pathogens in northeast Thailand</article-title>. <source>Am J Trop Med Hyg</source>
<year>2017</year>;<volume>97</volume>:<fpage>1695</fpage>.<pub-id pub-id-type="pmid">29016319</pub-id>
</mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><name><surname>Chantratita</surname><given-names>N</given-names></name>, <name><surname>Phunpang</surname><given-names>R</given-names></name>, <name><surname>Yarasai</surname><given-names>A</given-names></name>, <name><surname>Dulsuk</surname><given-names>A</given-names></name>, <name><surname>Yimthin</surname><given-names>T</given-names></name>, <name><surname>Onofrey</surname><given-names>LA</given-names></name>, <etal/>
<article-title>Characteristics and one year outcomes of melioidosis patients in northeastern Thailand: a prospective, multicenter cohort study</article-title>. <source>Lancet Reg HealthSoutheast Asia</source>
<year>2023</year>;<fpage>9</fpage>.</mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><name><surname>Chowdhury</surname><given-names>FR</given-names></name>, <name><surname>Jilani</surname><given-names>MSA</given-names></name>, <name><surname>Barai</surname><given-names>L</given-names></name>, <name><surname>Rahman</surname><given-names>T</given-names></name>, <name><surname>Saha</surname><given-names>MR</given-names></name>, <name><surname>Amin</surname><given-names>MR</given-names></name>, <etal/>
<article-title>Melioidosis in Bangladesh: a clinical and epidemiological analysis of culture-confirmed cases</article-title>. <source>Trop Med Infect Dis</source>
<year>2018</year>;<volume>3</volume>:<fpage>40</fpage>.<pub-id pub-id-type="pmid">30274436</pub-id>
</mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><name><surname>Barai</surname><given-names>L</given-names></name>, <name><surname>Jilani</surname><given-names>MSA</given-names></name>, <name><surname>Haq</surname><given-names>JA</given-names></name>. <article-title>Melioidosis case reports and review of cases recorded among Bangladeshi population from 1988&#x02013;2014</article-title>. <source>Ibrahim Med Coll J</source>
<year>2014</year>;<volume>8</volume>:<fpage>25</fpage>&#x02013;<lpage>31</lpage>.</mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><name><surname>Raja</surname><given-names>NS</given-names></name>, <name><surname>Scarsbrook</surname><given-names>C</given-names></name>. <article-title>Burkholderia pseudomallei causing bone and joint infections: a clinical update</article-title>. <source>Infect Dis Ther</source>
<year>2016</year>;<volume>5</volume>:<fpage>17</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="pmid">26728713</pub-id>
</mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><name><surname>Jayarajah</surname><given-names>U</given-names></name>, <name><surname>Arulanantham</surname><given-names>A</given-names></name>, <name><surname>Koculen</surname><given-names>V</given-names></name>, <name><surname>Palkumbura</surname><given-names>C</given-names></name>, <name><surname>Faleel</surname><given-names>A</given-names></name>, <name><surname>Sooriyarachchi</surname><given-names>R</given-names></name>. <article-title>Burkholderia pseudomallei peri-prosthetic infection following medial malleolar internal fixation: a case report</article-title>. <source>BMC Infect Dis</source>
<year>2020</year>;<volume>20</volume>:<fpage>1</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>H</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Zhou</surname><given-names>X</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>, <name><surname>Mai</surname><given-names>W</given-names></name>, <name><surname>Huang</surname><given-names>H</given-names></name>, <etal/>
<article-title>Osteomyelitis and septic arthritis due to burkholderia pseudomallei: a 10-year retrospective melioidosis study from south China</article-title>. <source>Front Cell Infect Microbiol</source>
<year>2021</year>;<volume>11</volume>:654745.</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Fig. 1.</label><caption><p id="P36">X ray of left hip joint (Lateral view).</p></caption><graphic xlink:href="nihms-2108614-f0001" position="float"/></fig><fig position="float" id="F2"><label>Fig. 2.</label><caption><p id="P37">Maximum likelihood phylogenetic tree of <italic toggle="yes">B. pseudomallei</italic>. RefSeq assemblies (n = 1755) were compared against strain B0557 (red branch), which shows it clusters (red dotted circle) with other Bangladesh examples within a larger East and Southeast Asia clade. The sample&#x02019;s reads and assembly are under NCBI&#x02019;s accession SAMN49682048. Core alignment size was 1272,732 bp, core SNP sites were 51,607 bp, and the scalebar represents 511 core SNPs. The tree is rooted to strain MSHR668.</p></caption><graphic xlink:href="nihms-2108614-f0002" position="float"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p id="P38">Biochemistry profile of the patient presenting as septic arthritis in hip joint.</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Parameters</th><th align="left" valign="middle" rowspan="1" colspan="1">Result</th><th align="left" valign="middle" rowspan="1" colspan="1">Unit</th><th align="left" valign="middle" rowspan="1" colspan="1">Ref. Range</th></tr><tr><th colspan="4" align="left" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum Sodium</td><td align="left" valign="top" rowspan="1" colspan="1">134</td><td align="left" valign="top" rowspan="1" colspan="1">mmol/L</td><td align="left" valign="top" rowspan="1" colspan="1">136&#x02013;148</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum Potassium</td><td align="left" valign="top" rowspan="1" colspan="1">4.4</td><td align="left" valign="top" rowspan="1" colspan="1">mmol/L</td><td align="left" valign="top" rowspan="1" colspan="1">3.5&#x02013;5.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum Chloride</td><td align="left" valign="top" rowspan="1" colspan="1">102</td><td align="left" valign="top" rowspan="1" colspan="1">mmol/L</td><td align="left" valign="top" rowspan="1" colspan="1">98&#x02013;108</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum TCO2</td><td align="left" valign="top" rowspan="1" colspan="1">21</td><td align="left" valign="top" rowspan="1" colspan="1">mmol/L</td><td align="left" valign="top" rowspan="1" colspan="1">25&#x02013;29 (for Male)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum Creatinine</td><td align="left" valign="top" rowspan="1" colspan="1">2.8</td><td align="left" valign="top" rowspan="1" colspan="1">mg/dl</td><td align="left" valign="top" rowspan="1" colspan="1">0.67&#x02013;1.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum Urea</td><td align="left" valign="top" rowspan="1" colspan="1">64</td><td align="left" valign="top" rowspan="1" colspan="1">mg/dl</td><td align="left" valign="top" rowspan="1" colspan="1">10&#x02013;45</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CRP</td><td align="left" valign="top" rowspan="1" colspan="1">223.8</td><td align="left" valign="top" rowspan="1" colspan="1">mg/L</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c; 6 mg/L</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum Total Protein</td><td align="left" valign="top" rowspan="1" colspan="1">76.9</td><td align="left" valign="top" rowspan="1" colspan="1">gm/L</td><td align="left" valign="top" rowspan="1" colspan="1">63&#x02013;82</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum Albumin</td><td align="left" valign="top" rowspan="1" colspan="1">32.2</td><td align="left" valign="top" rowspan="1" colspan="1">gm/L</td><td align="left" valign="top" rowspan="1" colspan="1">34&#x02013;50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum Calcium</td><td align="left" valign="top" rowspan="1" colspan="1">8.1</td><td align="left" valign="top" rowspan="1" colspan="1">mg/dl</td><td align="left" valign="top" rowspan="1" colspan="1">8.4&#x02013;10.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum Phosphate</td><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">mg/dl</td><td align="left" valign="top" rowspan="1" colspan="1">2.5&#x02013;4.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum Magnesium</td><td align="left" valign="top" rowspan="1" colspan="1">0.9</td><td align="left" valign="top" rowspan="1" colspan="1">mmol/L</td><td align="left" valign="top" rowspan="1" colspan="1">0.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum Ferritin</td><td align="left" valign="top" rowspan="1" colspan="1">782</td><td align="left" valign="top" rowspan="1" colspan="1">ng/dl</td><td align="left" valign="top" rowspan="1" colspan="1">30&#x02013;400</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Liver Function</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Bilirubin (Total)</td><td align="left" valign="top" rowspan="1" colspan="1">0.5</td><td align="left" valign="top" rowspan="1" colspan="1">mg/dl</td><td align="left" valign="top" rowspan="1" colspan="1">0.4&#x02013;1.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum AST (SGOT)</td><td align="left" valign="top" rowspan="1" colspan="1">42</td><td align="left" valign="top" rowspan="1" colspan="1">U/L</td><td align="left" valign="top" rowspan="1" colspan="1">Up to 37</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serum ALT (SGPT)</td><td align="left" valign="top" rowspan="1" colspan="1">44</td><td align="left" valign="top" rowspan="1" colspan="1">U/L</td><td align="left" valign="top" rowspan="1" colspan="1">Up to 40</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alkaline Phosphatase</td><td align="left" valign="top" rowspan="1" colspan="1">113</td><td align="left" valign="top" rowspan="1" colspan="1">U/L</td><td align="left" valign="top" rowspan="1" colspan="1">39&#x02013;117 (Adult)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fasting blood sugar</td><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">mmol/L</td><td align="left" valign="top" rowspan="1" colspan="1">3.9&#x02013;5.6 mmol/L</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Random blood sugar</td><td align="left" valign="top" rowspan="1" colspan="1">15.9</td><td align="left" valign="top" rowspan="1" colspan="1">mmol/L</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c; 6.9 mmol/L</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HbA1c</td><td align="left" valign="top" rowspan="1" colspan="1">12.6</td><td align="left" valign="top" rowspan="1" colspan="1">%</td><td align="left" valign="top" rowspan="1" colspan="1">4&#x02013;6 %</td></tr></tbody></table></table-wrap></floats-group></article>